• News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in allergan

Glenmark Stock Up After US Approval To Its Savella Generic

Shares of drug maker Glenmark Pharmaceuticals rose 0.52 per cent to Rs 868. 45 a unit on BSE on Friday, a day that saw the benchmark Sensex down by at least 50 points

Read More

Dr Reddy's To Buy Eight Products In US For $350 Million

The portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business, the Hyderabad-based firm said

Read More

Investors Stick With Pfizer CEO After Allergan Deal Collapse

In 2014, Pfizer failed in its unsolicited $118 billion bid to buy London-based drugmaker AstraZeneca Plc after that deal ran into staunch opposition from British politicians

Read More

Obama's Inversion Curbs Kill Pfizer's $160 Billion Allergan Deal

Pfizer will have to pay Allergan up to $400 million for its expenses as a result of terminating the deal, according to their merger agreement

Read More

Teva Set To Win EU Okay For $40.5 Billion Allergan Deal

Teva will gain bigger economies of scale, a crucial element in the low-margin generic drugs business, with the deal, the largest in Israel's corporate history.

Read More

Pfizer Set To Buy Allergan For $150 Billion To Create World's Biggest Drug Maker

The deal is sure to draw political ire in a US presidential election year because Pfizer would redomicile to Ireland, where Allergan is registered, in a so-called 'inversion' that would slash its corporate tax rate

Read More

Pfizer-Allergan Talks Accelerate Amid New Inversion Clamp-down

Pfizer is negotiating a price of $370 to $380 for each Allergan share. Allergan shares ended trading on Wednesday at $310.8 per share

Read More